{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:46:23Z","timestamp":1751535983586,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00380-024-02369-7","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T16:03:14Z","timestamp":1709049794000},"page":"505-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features, future cardiac events, and prognostic factors following percutaneous coronary intervention in young female patients"],"prefix":"10.1007","volume":"39","author":[{"given":"Yosuke","family":"Tatami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2260-1942","authenticated-orcid":false,"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Umemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuro","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyokazu","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"N-registry investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"2369_CR1","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.STR.0000090348.52943.A2","volume":"34","author":"M Kubo","year":"2003","unstructured":"Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M (2003) Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 34:2349\u20132354","journal-title":"Stroke"},{"key":"2369_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0002-8703(05)80050-X","volume":"119","author":"D Levy","year":"1990","unstructured":"Levy D, Wilson PW, Anderson KM, Castelli WP (1990) Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J 119:712\u2013717","journal-title":"Am Heart J"},{"key":"2369_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0895-4356(03)00055-6","volume":"56","author":"LE Chambless","year":"2003","unstructured":"Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M, Nieto FJ (2003) Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol 56:880\u2013890","journal-title":"J Clin Epidemiol"},{"key":"2369_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495\u20131504","journal-title":"N Engl J Med"},{"key":"2369_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","volume":"384","author":"CE Lewis","year":"2021","unstructured":"SPRINT Research Group, Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT Jr, Ambrosius WT (2021) Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 384:1921\u20131930","journal-title":"N Engl J Med"},{"key":"2369_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1253\/circj.70.1256","volume":"70","author":"Japanese Coronary Artery Disease Study Investigators","year":"2006","unstructured":"Japanese Coronary Artery Disease Study Investigators (2006) Current status of the background of patients with coronary artery disease in Japan. Circ J 70:1256\u20131262","journal-title":"Circ J"},{"key":"2369_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.117.027252","volume":"136","author":"NJ Pagidipati","year":"2017","unstructured":"Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED, Tecos Study Group (2017) Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). Circulation 136:1193\u20131203","journal-title":"Circulation"},{"key":"2369_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1023\/A:1015684029550","volume":"17","author":"Y Sharabi","year":"2001","unstructured":"Sharabi Y, Grotto I, Huerta M, Eldad A, Green MS (2001) Risk factor profile for atherosclerosis among young adults in Israel\u2013results of a large-scale survey from the young adult periodic examinations in Israel (YAPEIS) database. Eur J Epidemiol 17:757\u2013764","journal-title":"Eur J Epidemiol"},{"key":"2369_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00240064","volume":"160\u2013161","author":"T Pelzer","year":"1996","unstructured":"Pelzer T, Shamim A, Neyses L (1996) Estrogen effects in the heart. Mol Cell Biochem 160\u2013161:307\u2013313","journal-title":"Mol Cell Biochem"},{"key":"2369_CR10","first-page":"3913","volume":"82","author":"DF Skafar","year":"1997","unstructured":"Skafar DF, Xu R, Morales J, Ram J, Sowers JR (1997) Clinical review 91: Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab 82:3913\u20133918","journal-title":"J Clin Endocrinol Metab"},{"key":"2369_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","volume":"5","author":"M Trinder","year":"2020","unstructured":"Trinder M, Francis GA, Brunham LR (2020) Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease. JAMA Cardiol 5:390\u2013399","journal-title":"JAMA Cardiol"},{"key":"2369_CR12","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1161\/01.CIR.92.9.2432","volume":"92","author":"J Hung","year":"1995","unstructured":"Hung J, Lam JY, Lacoste L, Letchacovski G (1995) Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 92:2432\u20132436","journal-title":"Circulation"},{"key":"2369_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12872-020-01577-z","volume":"20","author":"R Liu","year":"2020","unstructured":"Liu R, Xu F, Zhou Y, Liu T (2020) The characteristics of risk factors in Chinese young women with acute coronary syndrome. BMC Cardiovasc Disord 20:290","journal-title":"BMC Cardiovasc Disord"},{"key":"2369_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3949\/ccjm.60.5.393","volume":"60","author":"AZ Arnold","year":"1993","unstructured":"Arnold AZ, Moodie DS (1993) Coronary artery disease in young women: risk factor analysis and long-term follow-up. Cleve Clin J Med 60:393\u2013398","journal-title":"Cleve Clin J Med"},{"key":"2369_CR15","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.2174\/0929867322666150904105941","volume":"22","author":"G Kolovou","year":"2015","unstructured":"Kolovou G, Kolovou V, Koutelou M, Mavrogeni S (2015) Atherosclerotic and Non-Atherosclerotic Coronary Heart Disease in Women. Curr Med Chem 22:3555\u20133564","journal-title":"Curr Med Chem"},{"key":"2369_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2217\/WHE.15.10","volume":"11","author":"J Kurth","year":"2015","unstructured":"Kurth J, Malik S (2015) Reducing women\u2019s cardiovascular disease risk profile. Womens Health (Lond) 11:385\u2013397","journal-title":"Womens Health (Lond)"},{"key":"2369_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.amjcard.2018.10.038","volume":"123","author":"Y Negishi","year":"2019","unstructured":"Negishi Y, Tanaka A, Ishii H, Takagi K, Inoue Y, Uemura Y, Umemoto N, Yoshioka N, Morishima I, Asano H, Watarai M, Shibata N, Suzuki S, Murohara T (2019) Contrast-Induced Nephropathy and Long-Term Clinical Outcomes Following Percutaneous Coronary Intervention in Patients With Advanced Renal Dysfunction (Estimated Glomerular Filtration Rate <30 ml\/min\/1.73 m(2)). Am J Cardiol 123:361\u2013367","journal-title":"Am J Cardiol"},{"key":"2369_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1253\/circj.CJ-19-0467","volume":"84","author":"N Yoshioka","year":"2019","unstructured":"Yoshioka N, Takagi K, Morishima I, Morita Y, Uemura Y, Inoue Y, Umemoto N, Shibata N, Negishi Y, Yoshida R, Tanaka A, Ishii H, Murohara T, N-registry investigators (2019) Influence of Preadmission Frailty on Short- and Mid-Term Prognoses in Octogenarians With ST-Elevation Myocardial Infarction. Circ J 84:109\u2013118","journal-title":"Circ J"},{"key":"2369_CR19","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1253\/circj.CJ-20-0545","volume":"85","author":"N Shibata","year":"2021","unstructured":"Shibata N, Umemoto N, Tanaka A, Takagi K, Iwama M, Uemura Y, Inoue Y, Negishi Y, Ohashi T, Tanaka M, Yoshida R, Shimizu K, Tashiro H, Yoshioka N, Morishima I, Noda T, Watarai M, Asano H, Tanaka T, Tatami Y, Takada Y, Ishii H, Murohara T, N-registry investigators (2021) Clinical Outcomes Following Emergent Percutaneous Coronary Intervention for Acute Total\/Subtotal Occlusion of the Left Main Coronary Artery. Circ J 85:1789\u20131796","journal-title":"Circ J"},{"key":"2369_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2459\/JCM.0000000000001067","volume":"22","author":"Y Inoue","year":"2021","unstructured":"Inoue Y, Tanaka A, Asano H, Uemura Y, Takagi K, Ohashi T, Tanaka M, Umemoto N, Ajioka M, Tashiro H, Watarai M, Morishima I, Tatami Y, Takada Y, Shimizu K, Ishii H, Murohara T (2021) Clinical characteristics and treatment of Spontaneous Coronary Artery Dissection in Young Women Undergoing Percutaneous Coronary Intervention. J Cardiovasc Med (Hagerstown) 22:14\u201319","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2369_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12928-019-00615-8","volume":"35","author":"R Yoshida","year":"2020","unstructured":"Yoshida R, Ishii H, Morishima I, Tanaka A, Takagi K, Yoshioka N, Kataoka T, Tashiro H, Hitora Y, Niwa K, Furusawa K, Morita Y, Tsuboi H, Murohara T (2020) Prognostic impact of recanalizing chronic total occlusion in non-infarct related arteries on long-term clinical outcomes in acute myocardial infarction patients undergoing primary percutaneous coronary intervention. Cardiovasc Interv Ther 35:259\u2013268","journal-title":"Cardiovasc Interv Ther"},{"key":"2369_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, ESC Scientific Document Group (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J 40:237\u2013269","journal-title":"Eur Heart J"},{"key":"2369_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12928-016-0407-z","volume":"32","author":"K Ando","year":"2017","unstructured":"Ando K, Ishii K, Tada E, Kataoka K, Hirohata A, Goto K, Kobayashi K, Tsutsui H, Nakahama M, Nakashima H, Uchikawa S, Kanda J, Yasuda S, Yajima J, Kitabayashi H, Sakurai S, Nakanishi K, Inoue N, Noike H, Hasebe T, Sato T, Yamasaki M, Kimura T (2017) Prospective multi-center registry to evaluate efficacy and safety of the newly developed diamond-like carbon-coated cobalt-chromium coronary stent system. Cardiovasc Interv Ther 32:225\u2013232","journal-title":"Cardiovasc Interv Ther"},{"key":"2369_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"2369_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12928-021-00832-0","volume":"37","author":"H Ando","year":"2022","unstructured":"Ando H, Yamaji K, Kohsaka S, Ishii H, Wada H, Yamada S, Sawano M, Inohara T, Numasawa Y, Ikari Y, Amano T, J-PCI Registry Investigators (2022) Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes. Cardiovasc Interv Ther 37:243\u2013247","journal-title":"Cardiovasc Interv Ther"},{"key":"2369_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jacasi.2022.03.013","volume":"2","author":"H Ando","year":"2022","unstructured":"Ando H, Yamaji K, Kohsaka S, Ishii H, Sakakura K, Goto R, Nakano Y, Takashima H, Ikari Y, Amano T (2022) Clinical Presentation and In-Hospital Outcomes of Acute Myocardial Infarction in Young Patients: Japanese Nationwide Registry. JACC Asia 2:574\u2013585","journal-title":"JACC Asia"},{"key":"2369_CR27","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis C, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073\u20132081","journal-title":"Lancet"},{"key":"2369_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","volume":"39","author":"PJ Best","year":"2002","unstructured":"Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113\u20131119","journal-title":"J Am Coll Cardiol"},{"key":"2369_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.ki.5002017","volume":"71","author":"K Yamagata","year":"2007","unstructured":"Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A (2007) Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71:159\u2013166","journal-title":"Kidney Int"},{"key":"2369_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"2369_CR31","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi M, Towler D, Slatopolsky E (2009) Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20:1453\u20131464","journal-title":"J Am Soc Nephrol"},{"key":"2369_CR32","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378","journal-title":"Kidney Int"},{"key":"2369_CR33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00380-015-0712-y","volume":"31","author":"Y Takayama","year":"2016","unstructured":"Takayama Y, Yasuda Y, Suzuki S, Shibata Y, Tatami Y, Shibata K, Niwa M, Sawai A, Morimoto R, Kato S, Ishii H, Maruyama S, Murohara T (2016) Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients. Heart Vessels 31:1030\u20131037","journal-title":"Heart Vessels"},{"key":"2369_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.atherosclerosis.2015.10.016","volume":"243","author":"Y Tatami","year":"2015","unstructured":"Tatami Y, Yasuda Y, Suzuki S, Ishii H, Sawai A, Shibata Y, Ota T, Shibata K, Niwa M, Morimoto R, Hayashi M, Kato S, Maruyama S, Murohara T (2015) Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease. Atherosclerosis 243:349\u2013355","journal-title":"Atherosclerosis"},{"key":"2369_CR35","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2012.16817","volume":"308","author":"SI Hallan","year":"2012","unstructured":"Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J, Chronic Kidney Disease Prognosis Consortium (2012) Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308:2349\u20132360","journal-title":"JAMA"},{"key":"2369_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","volume":"354","author":"P Ruggenenti","year":"1999","unstructured":"Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359\u2013364","journal-title":"Lancet"},{"key":"2369_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, Renaal Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861\u2013869","journal-title":"N Engl J Med"},{"key":"2369_CR38","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429\u20131435","journal-title":"N Engl J Med"},{"key":"2369_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","volume":"368","author":"GR Dagenais","year":"2006","unstructured":"Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S (2006) Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 368:581\u2013588","journal-title":"Lancet"},{"key":"2369_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"2369_CR41","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjostrom CD, Toto RD, Langkilde AM, Wheeler DC, Trial Committees Investigators DAPA-CKD (2020) Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 383:1436\u20131446","journal-title":"N Engl J Med"},{"key":"2369_CR42","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","volume":"400","author":"Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialist's Consortium","year":"2022","unstructured":"Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialist\u2019s Consortium (2022) Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet 400:1788\u20131801","journal-title":"Lancet"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02369-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02369-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02369-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T06:02:17Z","timestamp":1714802537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02369-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02369-7","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"9 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.I. received lecture fees from Astellas Pharma Inc. Daiichi-Sankyo Pharma Inc. and MSD K.K. T. M. received lecture fees from BayerPharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Pfizer Japan Inc., Sanofi-aventis K.K., and Takeda Pharmaceutical Co., Ltd. T.M.received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc, Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K.K., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}